Publication:
Effectiveness and Safety of Clonazepam, Pregabalin, and Alpha Lipoic Acid for the Treatment of Burning Mouth Syndrome

dc.contributor.authorÇİNAR, SALİH LEVENT
dc.contributor.authorKARTAL, DEMET
dc.contributor.authorPergel, TAHA
dc.contributor.authorBORLU, MURAT
dc.contributor.institutionauthorPERGEL, TAHA
dc.date.accessioned2020-12-17T20:59:19Z
dc.date.available2020-12-17T20:59:19Z
dc.date.issued2018-03-01T00:00:00Z
dc.description.abstractObjective: Burning mouth syndrome is characterized by pain in the oral mucosa with no visible organic pathology. Few treatment options are available; however, none of them are gold-standard. Here we evaluated the effectiveness and safety of Clonazepam. pregabalin. and alpha lipoic acid for treating burning mouth syndrome.
dc.identifier.citationÇİNAR S. L. , KARTAL D., Pergel T., BORLU M., -Effectiveness and Safety of Clonazepam, Pregabalin, and Alpha Lipoic Acid for the Treatment of Burning Mouth Syndrome-, ERCIYES MEDICAL JOURNAL, cilt.40, ss.35-38, 2018
dc.identifier.doi10.5152/etd.2018.17160
dc.identifier.scopus85046722758
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27736
dc.identifier.wosWOS:000432307500008
dc.titleEffectiveness and Safety of Clonazepam, Pregabalin, and Alpha Lipoic Acid for the Treatment of Burning Mouth Syndrome
dc.typeArticle
dspace.entity.typePublication
local.avesis.ide5a1e326-5d7b-4494-a75b-fb239fdfa139
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublication98473453-eb80-4aab-a087-f6081a9143b7
relation.isAuthorOfPublication.latestForDiscovery98473453-eb80-4aab-a087-f6081a9143b7

Files